Medical Device

Medigus (NASDAQ:MDGS) a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, today announced financial results for the fourth quarter and fiscal year ended December 31, 2017. As quoted in the press release: Total revenues in the fourth quarter of 2017 were $154,000, an increase of $101,000, or 190% compared …

Medigus (NASDAQ:MDGS) a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, today announced financial results for the fourth quarter and fiscal year ended December 31, 2017.

As quoted in the press release:

  • Total revenues in the fourth quarter of 2017 were $154,000, an increase of $101,000, or 190% compared to the same period in 2016
  • Gross profit in the fourth quarter of 2017 was $80,000, an increase of $49,000, or 163% compared to the same period in 2016
  • Research and development expenses in the fourth quarter of 2017 were $464,000, a decrease of $170,000, or 27% compared to the same period in 2016
  • Sales and marketing expenses in the fourth quarter of 2017 were $305,000, an increase of $25,000, or 9% compared to the same period in 2016

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20584.84+201.09
TSXV713.15+11.41
DOW32641.74+521.46
S&P 5004053.97+75.24
NASD11713.33+278.59
ASX7155.20+26.40

COMMODITIES

Commodities
Gold1847.09-6.96
Silver21.92-0.06
Copper4.260.00
Palladium2004.05+6.05
Platinum947.53+0.53
Oil114.45+4.12
Heating Oil3.85+0.10
Natural Gas9.31+0.34

DOWNLOAD FREE REPORTS

×